Press release
Global Vaccines Market to Reach $67.91 Billion by 2030, Fueled by Innovation, Expanding Immunization Programs, and Rising Disease Burden
According to MarketsandMarkets Trademark , the latest research report, "Vaccines Market [https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Global Forecast to 2030," the global vaccines market (excluding COVID-19) is projected to grow from USD 47.65 billion in 2025 to USD 67.91 billion by 2030, registering a CAGR of 7.3% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1155 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1155&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Browse
* 437 Market Data Tables
* 61 Figures
* 449 Pages and in-depth TOC on " Vaccines Market - Global Forecast to 2030".
What is driving this sustained market expansion, and why does it matter now for global decision-makers?
The growth trajectory is underpinned by increasing investments in vaccine development, alongside the continuous launch of innovative products that improve accessibility and coverage. As infectious diseases continue to pose significant global health risks, governments and healthcare organizations are prioritizing preventive strategies, thereby accelerating vaccine adoption worldwide.
How are technological advancements reshaping the competitive landscape? Breakthroughs in mRNA platforms, recombinant technologies, and advanced delivery systems are enabling faster, more efficient vaccine development. These innovations not only enhance efficacy but also reduce time-to-market, offering pharmaceutical companies and investors new avenues for value creation.
Where is demand accelerating most rapidly? Emerging markets are witnessing a surge in immunization programs, supported by global health initiatives and funding bodies. Expanded access to vaccines in these regions is playing a pivotal role in increasing overall vaccination rates, while strengthening healthcare infrastructure.
Who are the key beneficiaries of this evolving ecosystem? Governments, healthcare providers, and pharmaceutical companies are leveraging strong policy support and funding to scale immunization efforts. Additionally, organizations such as WHO, UNICEF, and Gavi are driving global vaccination campaigns, particularly in pediatric populations.
Segment Insights:
Why does pneumococcal disease dominate the market by indication? In 2024, pneumococcal vaccines accounted for the largest market share, primarily due to the high global burden of infections among children under five and elderly populations. Widespread inclusion in national immunization schedules, combined with ongoing advancements in conjugate and polysaccharide vaccines, continues to strengthen this segment's leadership.
What is fueling the rapid growth of pediatric vaccines? The pediatric segment is expected to register the fastest growth through 2030. This trend is driven by rising awareness among parents, increasing prevalence of infectious diseases in children, and the introduction of combination vaccines that reduce the number of injections. Strategic investments and large-scale immunization initiatives are further accelerating adoption across global markets.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Regional Insights:
Where does North America stand in the global landscape? In 2024, North America accounted for the largest share of the vaccines market. The region's dominance is attributed to its advanced healthcare infrastructure, strong government immunization programs, and early adoption of cutting-edge technologies such as mRNA vaccines. Robust R&D investments, favorable reimbursement frameworks, and heightened public awareness have further reinforced its leadership position.
Who are the key players shaping the future of the vaccines market?
Leading companies including Merck & Co., Inc., GSK Plc, Pfizer, Inc., Sanofi, AstraZeneca, Johnson & Johnson Services Inc., Emergent, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd, and CSL are actively investing in R&D, strategic collaborations, and product innovation to strengthen their market positions.
How will the competitive landscape evolve? With a strong development pipeline and increasing focus on therapeutic vaccines, market players are expected to unlock new growth opportunities, particularly in addressing unmet medical needs and emerging infectious diseases.
Related Reports:
Veterinary Vaccines [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030
Vaccine Adjuvants Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2029
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-vaccines-market-to-reach-6791-billion-by-2030-fueled-by-innovation-expanding-immunization-programs-and-rising-disease-burden]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Vaccines Market to Reach $67.91 Billion by 2030, Fueled by Innovation, Expanding Immunization Programs, and Rising Disease Burden here
News-ID: 4457041 • Views: …
More Releases from ABNewswire
How Canton, OH Homeowners Reduce Their Electric Bill with Efficient Upgrades
Image: https://www.abnewswire.com/upload/2026/04/ccc8ca1654524ffc1c230d3288018160.jpg
The cost of living and maintaining a home in Northeast Ohio can fluctuate significantly depending on the season and the condition of your home's electrical infrastructure. Many homeowners in Canton find themselves frustrated by rising utility costs, often unaware that their outdated electrical components are the primary culprits behind high monthly bills. Efficient electrical upgrades are no longer just a luxury for high end modern homes; they have become…
NextGen Owners Bridge Fund Launches Platform to Address the Growing Financing Ga …
Platform launches with $25 million in initial deployment capacity, supported by a consortium of private capital partners, including family offices
NextGen Owners Bridge Fund today announced the launch of the NextGen Owners Bridge platform, designed to address a rapidly expanding gap in the market for business acquisition financing and ownership transition.
As millions of baby boomer-owned businesses approach transition over the next decade, a structural disconnect has emerged between willing sellers and…
Logistics Automation Market Future Prospects, Leading Companies, Latest Opportun …
Logistics Automation Market by Offering (Automated Guided Vehicles (AGVs), Autonomous Mobile Robots (AMRs), Automated Storage & Retrieval Systems, Conveyors, Warehouse Management Systems), Technology (RPA, Big Data, Blockchain) - Global Forecast to 2029
The global logistics automation market [https://www.marketsandmarkets.com/Market-Reports/logistics-automation-market-83657139.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=logistics-automation-market] is projected to increase from an estimated USD 35.14 billion in 2024 to USD 52.53 billion by 2029, growing at a compound yearly growth rate of 8.4%. Smart warehousing systems with IoT, artificial…
Single-use Bioprocessing Market to Reach $33.67 Billion by 2030
Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030
According to MarketsandMarkets Trademark , the global Single-use Bioprocessing Market [https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is set for substantial expansion, projected to grow from USD 18.01 billion in 2025 to USD 33.67 billion by 2030, at a CAGR of 13.3%. As biopharmaceutical companies prioritize agility, cost efficiency,…
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Flu Vaccine (Influenza Vaccine) Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Flu Vaccine (Influenza Vaccine) Market Breakdown by Application (For Children (6 months to 3 years), For Adults and Children over 3 years) by Type (Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines, Live Attenuated Virus Vaccines) and by Geography (North America, South…
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
